EXTRAWELL PHAR (00858) proposes to place up to 580 million shares at a premium of approximately 1.96% to raise net proceeds of approximately HK$29.4 million

date
22:54 30/10/2026
avatar
GMT Eight
ExtraWell Pharma (00858) announced that on October 30, 2026, the company proposes to place up to 580 million placing shares, representing 20% of the company's existing issued share capital as at the date of this announcement and approximately 16.67% of the company's issued share capital as enlarged by the issue of the placing shares.
EXTRAWELL PHAR (00858) announces that on October 30, 2026, the Company proposes to place up to 580 million placing shares, representing 20% of the Company's existing issued share capital as at the date of this announcement and approximately 16.67% of the Company's issued share capital as enlarged by the issue of the placing shares. The placing price of HK$0.052 per placing share represents a premium of approximately 1.96% over the closing price of HK$0.051 per share on October 30. Assuming the maximum number of placing shares is placed under the placing agreement, the gross proceeds from the placing will be approximately HK$30.2 million, and the net proceeds will be approximately HK$29.4 million. It is expected that (a) approximately HK$9.8 million (representing approximately 33.33% of the maximum net proceeds) will be used to expand the Group's electronic module and related product trading business; and (b) approximately HK$19.6 million (representing approximately 66.67% of the maximum net proceeds) will be used by the Group to support the launch of its electronic module and related product manufacturing, sales, and research and development business.